CHEMOTHERAPY AND SURVIVAL IN NONSMALL CELL LUNG-CANCER - 3 YEARS LATER

被引：10

作者：

BUCCHERI, G

机构：

来源：

关键词：

D O I：

10.1378/chest.106.4.990

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：990 / 992

页数：3

共 28 条

[1] CHEMOTHERAPY AND SURVIVAL IN NON-SMALL-CELL LUNG-CANCER - THE OLD VEXATA QUESTIO
BUCCHERI, G
[J]. CHEST, 1991, 99 (06) : 1328 - 1329
[2] BUCCHERI G, 1990, LUNG CANCER, V6, P87
[3] BUCCHERI GF, 1989, CANCER, V63, P428, DOI 10.1002/1097-0142(19890201)63:3<428::AID-CNCR2820630305>3.0.CO
[4] 2-V
[5] CISPLATIN CYCLOPHOSPHAMIDE MITOMYCIN COMBINATION CHEMOTHERAPY WITH SUPPORTIVE CARE VERSUS SUPPORTIVE CARE ALONE FOR TREATMENT OF METASTATIC NON-SMALL-CELL LUNG-CANCER
CARTEI, G
CARTEI, F
CANTONE, A
CAUSARANO, D
GENCO, G
TOBALDIN, A
INTERLANDI, G
GIRALDI, T
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (10): : 794 - 800
[6] A RANDOMIZED TRIAL OF ALTERNATING CHEMOTHERAPY VERSUS BEST SUPPORTIVE CARE IN ADVANCED NON-SMALL-CELL LUNG-CANCER
CELLERINO, R
TUMMARELLO, D
GUIDI, F
ISIDORI, P
RASPUGLI, M
BISCOTTINI, B
FATATI, G
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (08) : 1453 - 1461
[7] IS CHEMOTHERAPY FOR NONSMALL CELL LUNG-CANCER WORTHWHILE
COATES, A
FORBES, J
[J]. LANCET, 1993, 342 (8862) : 4 - 4
[8] CORMIER Y, 1982, CANCER, V50, P845, DOI 10.1002/1097-0142(19820901)50:5<845::AID-CNCR2820500507>3.0.CO
[9] 2-S
[10] DURRANT KR, 1971, LANCET, V1, P715